FDA Approves Bayer’s Sunharbo, the First Factor XIa Inhibitor, to Help Prevent Repeat Strokes
The FDA approved Bayer’s Sunharbo, the first factor XIa inhibitor, to reduce the risk of another stroke in certain adults taking antiplatelet therapy.
